Treatment of lung cancer is changing! – Tumor Board Tuesday

Tumor Board Tuesday shared on X/Twitter:

“Tumor Board Tuesday

Treatment of lung cancer is changing! New approvals for perioperative immunotherapy can be confusing. This week, Shruti Patel and Narjust Florez broke it down:
– Biomarker testing is the key,
– Role for perioperative treatment.

Read on for the case wrap-up and hear from Narjust Florez.”

Source: Tumor Board Tuesday/X

About OncoDaily

OncoDaily was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within a short period of time it became one of the leading oncology media platforms globally.

OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.

The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we”.